Biotech Research
Filter News
Found 720 articles
-
BTS Research Appoints Mark Crane as Vice President, Business Development
11/15/2018
BTS Research is delighted to announce the addition of Mark T. Crane as Vice President of Business Development.
-
New finding adds proof microbes are at Alzheimer's "crime scene", says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest, Inc.
11/15/2018
Upon analyzing the accumulated evidence that microbes inhabit or visit the brain and likely trigger Alzheimer's disease, Leslie Norins, MD, PhD, concluded, "The suspects have been reliably placed at the crime scene." Dr. Norins is CEO of Alzheimer's Germ Quest, Inc., an independent advocacy group for Alzheimer's research.
-
bluebird bio to Present at the Evercore ISI HealthCONx Conference
11/15/2018
bluebird bio (Nasdaq: BLUE) today announced that members of the management team will present at the Evercore ISI HealthCONx Conference, Wednesday, November 28, at 4:15 p.m. ET at the Boston Harbor Hotel, Boston.
-
NIH $1.4M grant supports study into precision bioelectronic medicine
11/15/2018
Feinstein Institute for Medical Research Professor Larry Miller, MD, has received a one-year, $1.4 million grant from the National Institutes of Health (NIH) to develop and test a non-invasive method that accesses nerves in the chest and abdomen.
-
Every year, Forbes creates a list of 30 Under 30, people under the age of 30 who have made a mark and show promise in various areas. They just came out with the 2019 30 Under 30: Healthcare. Here we highlight a dozen of the winners for their roles in biopharma-related endeavors.
-
SVB Financial Group to Acquire Healthcare Investment Bank Leerink Partners
11/13/2018
Strategic combination will strengthen SVB's position as the leading financial services provider to Healthcare and Life Science Companies
-
ABL, Inc. Announces Appointment of Jarlath Keating as President and Chief Executive Officer
11/12/2018
ABL, Inc. (ABL), a leading global contract research and manufacturing service provider to the biopharmaceutical industry, announces the appointment of Jarlath Keating as the new President and Chief Executive Officer of ABL, succeeding Dr. Thomas VanCott.
-
VALBIOTIS Announces Expansion of Application for VALEDIA to Include NASH Prevention
11/12/2018
New results demonstrate the clinical potential of VALEDIA for NASH risk reduction.
-
Singapore National Eye Centre, Singapore Eye Research Institute And Johnson & Johnson Vision Set Sights On Halting Global Myopia Epidemic
11/12/2018
New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition
-
November 9 Research Roundup: Coffee Reduces Risk of Alzheimer’s, Fish Can Decrease Asthma, and Ge...
11/10/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Hundreds of millions of dollars have been pledged by billionaires to advance scientific research.
-
Personalis, Inc. Launches ImmunoID NeXT, the First Platform Providing Characterization of a Tumor and Its Microenvironment From a Single Sample
11/9/2018
Personalis, a leader in advanced genomics for precision oncology, today announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT™.
-
Research teams from Salk Institute for Biological Studies, Stanford University, University Hospitals Cleveland Medical Center selected to study healthy brain aging, better treatments for neurodegenerative diseases
11/9/2018
Today, the American Heart Association, the world's leading voluntary organization focused on heart and brain health, and The Paul G. Allen Frontiers Group, a division of the Allen Institute, announced awardees of the American Heart Association-Allen Initiative in Brain Health and Cognitive Impairment, a new collaborative funding initiative launched earlier this year.
-
One of the biggest areas of research when it comes to cancer is prediction, because the sooner cancer is detected, the higher the chance that the patient will survive. In most cases, cancer is diagnosed after it has already entered into the advanced stages, which severely decreases the effectiven...
-
Arthritis Research Canada appoints first Honourary Patron
11/8/2018
Retired Chief Justice Beverley McLachlin lends name to arthritis research
-
Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review
11/7/2018
Company to initiate corporate restructuring, including ~60% reduction in force and significant reduction in operating expenses; potential to extend runway into at least 2H 2022 to preserve ability to capture Ipsen milestones
-
Shionogi to Present Clinical Data on Mulpleta® (lusutrombopag) at the Liver Meeting® 2018 of the American Association for the Study of Liver Diseases (AASLD)
11/7/2018
Shionogi & Co., Ltd. (hereafter "Shionogi") announced it will present four posters on Mulpleta® (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at The Liver Meeting®, the premiere annual meeting in the science and practice of hepatology from the American Association for the Study of Liver Diseases (AASLD) to be held in San Francisco, November 9-13, 2018.
-
VALBIOTIS Confirms the Publication of the Results from International Phase IIA Clinical Study Evaluating VALEDIA® for the Risk Reduction of Type 2 Diabetes, by Mid-2019
11/6/2018
VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, confirms the publication of the results evaluating VALEDIA® for the risk reduction of type 2 diabetes, by mid-2019.
-
Rare Diseases: Expected Benefits of a Physiological Absorption of Amino Acids in PKU Management. PKU GOLIKE® by APR Can Play a Role
11/6/2018
The recent article “Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria”, published on the last issue of “Nutrition Research Reviews”, sheds the light on PKU unmet needs, opening up new interesting avenues in PKU dietary management.
-
Life Image and Mendel.ai Partner to Bring the Power of AI to Accelerate Clinical Trial Process for Life Sciences and Academic Medical Facilities
11/6/2018
Life Image, the world's largest global network for sharing clinical and imaging data that is powered by industry leading interoperability standards, and Mendel.ai, a novel AI platform built to turbocharge oncology clinical research by rigorously examining every piece of EMR data, today announced a new strategic partnership that will facilitate the adoption and enhancement of AI in site selection and patient recruitment for oncology trials.